Liver disease and heart failure: Back and forth
In their clinical practice, physicians can face heart diseases (chronic or acute heart failure)
affecting the liver and liver diseases affecting the heart. Systemic diseases can also affect …
affecting the liver and liver diseases affecting the heart. Systemic diseases can also affect …
Atrial fibrillation and cancer; understanding the mysterious relationship through a systematic review
ABSTRACT Background Atrial Fibrillation (AFib) is the most common cardiac arrhythmia,
occurring in≈ 1% of the general population. An increased risk of malignancy among …
occurring in≈ 1% of the general population. An increased risk of malignancy among …
Metabolic activation and cytotoxicity of propafenone mediated by CYP2D6
J Li, J Shi, C Jia, W Li, Y Peng… - Chemical Research in …, 2022 - ACS Publications
Propafenone (PPF) is a class IC antidysrhythmic drug, which is commonly used for the
treatment of atrial fibrillation and other supraventricular arrhythmias. It is also a β …
treatment of atrial fibrillation and other supraventricular arrhythmias. It is also a β …
[HTML][HTML] Gastrointestinal side effects of antiarrhythmic medications: a review of current literature
W Amjad, W Qureshi, A Farooq, U Sohail, S Khatoon… - Cureus, 2017 - ncbi.nlm.nih.gov
Antiarrhythmic drugs are commonly prescribed cardiac drugs. Due to their receptor mimicry
with several of the gastrointestinal tract receptors, they can frequently lead to gastrointestinal …
with several of the gastrointestinal tract receptors, they can frequently lead to gastrointestinal …
Antiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts
Background The objective of this study was to determine the association between the use of
antiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts …
antiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts …
Propafenone-Induced Cholestatic Liver Injury: When Diagnosis Does Not Skip a Beat
AI Ferreira, V Macedo Silva, C Arieira… - GE-Portuguese Journal …, 2024 - karger.com
Introduction: Propafenone is a widely used class Ic antiarrhythmic drug that is mainly
metabolised by the liver. Hepatotoxicity associated with propafenone is rare, with only a few …
metabolised by the liver. Hepatotoxicity associated with propafenone is rare, with only a few …
PROPAFENONE-INDUCED LIVER INJURY IN AN ELDERLY PATIENT WITH PAROXYSMAL ATRIAL FIBRILLATION-A NEW CASE REPORT AND LITERATURE …
K Giedzicz, M Dytkowski, J Rentflejsz… - Acta Poloniae …, 2023 - search.ebscohost.com
Antiarrhythmic drugs are used more and more often, which is related to the aging of the
population and the growing number of arrhythmias, especially atrial fibrillation (AF). One of …
population and the growing number of arrhythmias, especially atrial fibrillation (AF). One of …
[图书][B] Erişkinlerde ACİL BAKIM
Page 1 ACİLBAKIM Editörler Prof. Dr. Fatma ETİ ASLAN Prof. Dr. Nermin OLGUN
akademisyenyayinevi akademisyen com AKADEMİSYEN KİTABEVİ Güncellenmiş …
akademisyenyayinevi akademisyen com AKADEMİSYEN KİTABEVİ Güncellenmiş …
Positive Inotropic Drugs and Drugs Used in Dysrhythmias
KA Mitręga, M Stankiewicz, TF Krzeminski - Side Effects of Drugs Annual, 2014 - Elsevier
Abstract The Side Effects of Drugs Annuals form a series of volumes in which the adverse
effects of drugs and adverse reactions to them are surveyed. The series supplements the …
effects of drugs and adverse reactions to them are surveyed. The series supplements the …
[PDF][PDF] RENAN DONOMAE IWAMOTO
CDABE FORMULAÇÃO-TESTE… - core.ac.uk
Propafenone hydrochloride is a 1C class of antiarrhythmic drug, which exerts a membrane
stabilizing effect on the myocardial cell. It has sodium channel blocking properties in the …
stabilizing effect on the myocardial cell. It has sodium channel blocking properties in the …